Investors

Investor centre

We are a global life science company supporting customers at the forefront of life science research. Our innovative products are used by hundreds of thousands of scientists worldwide.

Our purpose is to efficiently enable scientific breakthroughs by serving life scientists to achieve their mission, faster.

Our vision is to become the most influential life sciences company for researchers worldwide to support research, diagnostic and therapeutic applications.

Empowering faster scientific discovery

We envision a world in which all life scientists have access to the precise tools and solutions they need to accurately advance their research, resulting in faster breakthroughs in scientific understanding, and an accelerated transition of those breakthroughs into clinical applications. This, we believe, will ultimately lead to improved diagnoses, treatments and human health and wellbeing.

50% +

At least one Abcam product is cited in over half of all life science papers (CiteAb, 2019)

450 +

antibodies validated for use on third-party platforms or for diagnostic use

2000 +

custom products developed with our partners

20 +

products FDA approved, or in trials for a clinical or diagnostic application through partners

Serving life scientists globally

Every year around 750,000 life science researchers depend on our products and technical support. Located in over 130 countries, our customers work in academia, research institutes, and pharmaceutical, biotechnology and diagnostics companies. Together with high performance products, we provide expert customer support and rapid delivery, enabling our customers to reach their goals and achieve their mission, faster.

750,000

life science researchers

130 +

countries

Pioneering the discovery and development of reproducible proteomic tools

We are at the forefront of providing sustainable and reliable proteomic tools to the life science community. Our portfolio of off-the-shelf products and customized solutions are designed to perform consistently – first time, every time.

Our award-winning validated antibodies help scientists to save time and valuable resources, ensuring reproducible results and reliable scientific insights.

~ 100,000

Products on our catalogue

Learn about our products

20,000 +

Recombinant antibodies

Browse our full product range on abcam.com

Continuously innovating to support tomorrow’s needs

The need for new research tools is constant as users deepen scientific understanding and search for the next breakthrough. Driven to support their evolving needs, we continuously innovate, enhancing our in-house technical expertise and manufacturing capabilities to provide solutions that will enable scientific progress.

Our innovation

Progress through partnership

We are building partnerships across the life science community to co-create precision tools and novel reagents at a scale for use in drug discovery, in vitro diagnostics and therapeutic development. Leveraging our proprietary platforms and world-leading expertise, together with a flexible commercial approach we are passionate about collaborating to provide our partners with solutions and support to fast track their success.

Our partnering

Responsibly growing our impact

As a dynamic life science company, we want to take part in building the future and making life better for people all over the world. Together with impactful, ethical product innovation, we concentrate our sustainability efforts in the most important areas – providing a rewarding workplace for our teams, building long-term partnerships, engaging in the communities we work in and minimizing our environmental footprint.

Our sustainability

Sustaining financial and social value creation

Our strategy is designed to increase our positive impact on science and society and sustain profitable growth, generating long-term value for our shareholders and stakeholders.

Our strategy

An extraordinary team

Our talented team of over 1,500 colleagues around the world is our single biggest asset. By applying our expertise and constantly pushing boundaries, we strive to be the best in everything we do – delivering innovative solutions that are enabling global scientific and clinical breakthroughs, faster.

Nurturing employee excellence is key to our success and we invest in continuous learning, training and development of staff.

Our people Careers at Abcam

Our social and financial value creation model

Abcam is a global life sciences company providing highly validated antibodies and biological tools to the life scientist community. The success of our customers’ work, from basic research to translational science, diagnostics and therapeutic clinical programmes, relies on rigorous product quality, performance and reliability.

Operating transparently and responsibly, we manage our business to generate attractive and sustainable long-term economic returns and value for all our stakeholders.

Our business model

Our markets

Long-term industry forces across our markets remain attractive, with increases in research funding and capital investment supporting the growth of collaborative and global discovery networks.

Read about our markets

Our strategy

Abcam’s goal is to create sustainable social and financial value, by helping accelerate the pace of discovery, and the translation of those discoveries into social impact. We are uniformly committed to responsibly pursuing that goal through our purpose and have a clear strategy to achieve this.

View our strategy

Our board and leadership

We have a highly experienced Board and Senior Executive Team. The Board is responsible for the Group’s corporate governance, sets the Group’s strategy and policies, has overall responsibility for the oversight of risk and also monitors progress towards meeting its strategic objectives and annual plans. The Board discharges these responsibilities through a programme of meetings and also assesses whether or not, and to what extent, its obligations to the Company’s shareholders and other stakeholders are understood and met. This includes regular reviews of the Group’s financial performance and critical business issues.

View board and leadership